Yabao Pharmaceutical Group Co., Ltd

Yabao Pharmaceutical Group Co., Ltdverified

600351.SS

Price:

$6.65

Market Cap:

$4.65B

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, APIs, and pharmaceutical packaging materials in China and internationally. The company provides products for pediatrics, female healthcare, cardiovascular, big health, and elderly chronic diseases under the Diarrago, Baiyu, and Yabao brands. It also offers plastic bottles and cartons. The company provides its products in the form of injections, tablets, capsules, granules, pills, patches, freeze-dried powders, mixtures, suppositories, and solutions. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Yuncheng, China.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2002-09-26

Stock Exchange

SHH

Ticker

600351.SS

The Enterprise Value as of December 2025 (TTM) for Yabao Pharmaceutical Group Co., Ltd (600351.SS) is 4.11B

According to Yabao Pharmaceutical Group Co., Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 4.11B. This represents a change of 6.79% compared to the average of 3.85B of the last 4 quarters.

Yabao Pharmaceutical Group Co., Ltd (600351.SS) Historical Enterprise Value (quarterly & annually)

How has 600351.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Yabao Pharmaceutical Group Co., Ltd over the last ten years is 5.91B. The current 4.11B Enterprise Value has changed 6.86% with respect to the historical average. Over the past ten years (40 quarters), 600351.SS's Enterprise Value was at its highest in in the December 2015 quarter at 10.77B. The Enterprise Value was at its lowest in in the June 2024 quarter at 3.75B.

Quarterly (TTM)
Annual

Average

5.91B

Median

4.90B

Minimum

3.86B

Maximum

10.73B

Yabao Pharmaceutical Group Co., Ltd (600351.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Yabao Pharmaceutical Group Co., Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 70.69%

Maximum Annual Enterprise Value = 10.73B

Minimum Annual Increase = -39.02%

Minimum Annual Enterprise Value = 3.86B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20243.86B-20.93%
20234.88B13.53%
20224.30B-39.02%
20217.05B70.69%
20204.13B-16.08%
20194.92B6.71%
20184.61B-27.40%
20176.36B-22.88%
20168.24B-23.18%
201510.73B64.51%

Yabao Pharmaceutical Group Co., Ltd (600351.SS) Average Enterprise Value

How has 600351.SS Enterprise Value performed in the past?

The current Enterprise Value of Yabao Pharmaceutical Group Co., Ltd (600351.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.35B

5-year avg

4.85B

10-year avg

5.91B

Yabao Pharmaceutical Group Co., Ltd (600351.SS) Enterprise Value vs. Peers

How is 600351.SS’s Enterprise Value compared to its peers?

Yabao Pharmaceutical Group Co., Ltd’s Enterprise Value is less than Tibet Weixinkang Medicine Co., Ltd. (4.45B), less than ZhuZhou QianJin Pharmaceutical Co.,Ltd (4.17B), less than Jinhe Biotechnology Co. Ltd. (6.45B), less than Hunan Fangsheng Pharmaceutical Co., Ltd. (5.43B), greater than Wuhan Hiteck Biological Pharma Co.,Ltd (3.58B), less than LanZhou Foci Pharmaceutical Co.,Ltd. (4.46B), less than Zhejiang Starry Pharmaceutical Co.,Ltd. (6.50B), less than Tianjin Lisheng Pharmaceutical Co.,Ltd. (4.15B), less than HPGC Renmintongtai Pharmaceutical Corporation (8.17B), less than Harbin Medisan Pharmaceutical Co., Ltd. (4.64B),

Build a custom stock screener for Yabao Pharmaceutical Group Co., Ltd (600351.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Yabao Pharmaceutical Group Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Yabao Pharmaceutical Group Co., Ltd (600351.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Yabao Pharmaceutical Group Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Yabao Pharmaceutical Group Co., Ltd's Enterprise Value?

What is the highest Enterprise Value for Yabao Pharmaceutical Group Co., Ltd (600351.SS)?

What is the 3-year average Enterprise Value for Yabao Pharmaceutical Group Co., Ltd (600351.SS)?

What is the 5-year average Enterprise Value for Yabao Pharmaceutical Group Co., Ltd (600351.SS)?

How does the current Enterprise Value for Yabao Pharmaceutical Group Co., Ltd (600351.SS) compare to its historical average?